Carpal tunnel syndrome in HIV-infected patients treated with highly active antiretroviral therapy: other case reports.
A possible association between carpal tunnel syndrome and HIV infection has been suggested only once until now. Two patients with HIV infection are described who presented confirmed carpal tunnel syndrome while on prolonged protease inhibitor-containing highly active antiretroviral therapy (HAART). Their disease course and long-term outcome after medical and/or surgical interventions is presented and discussed according to available evidence from the literature. In our patients, carpal tunnel syndrome occurred in apparent absence of all presumed risk factors of this disease and metabolic abnormalities potentially related to HIV protease inhibitor administration.
Manfredi
R
R
Department of Clinical and Experimental Medicine, University of Bologna, S. Orsola Hospital, Italy. manfredi@med.unibo.it
Calza
L
L
Chiodo
F
F
D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D002349:Carpal Tunnel Syndrome / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D011480:Protease Inhibitors / Q000008:administration & dosage*; D016896:Treatment Outcome
D019380:Anti-HIV Agents; D011480:Protease Inhibitors